MENU

NEWSROOM

Title

  1. More accurate prediction of recurrence risk! The FUSCC team provides new "weapon" for postoperative management of colorectal cancer patients
  2. FUSCC-NMRRC joint webinar on “The treatment of oligo metastatic prostate cancer”
  3. Fudan University Shanghai Cancer Center revealed a unique T cell subset in the immune microenvironment of HPV-positive oropharyngeal carcinoma
  4. The study “clinical value of 68Ga-FAPI PET/CT in platinum-sensitive recurrent ovarian cancer” performed by Nuclear Medicine Department of Shanghai Cancer Center has been recognized internationally
  5. Prof. Zhiguo Luo and his team published the result of a phase II study of soft tissue sarcoma on Clinical Cancer Research
  6. FUSCC research team reveals characteristics of gut microbiome, metabolites, microbial enzyme genes in EO-CRC
  7. Chinese prostate cancer drug shows promising results
  8. Simultaneous cervicothoracic thymic cancer and thyroid cancer removed in a single operation
  9. The researches from Fudan University Shanghai Cancer Center mapped the proteogenomic profile of clear cell renal cell carcinoma
  10. A novel method to reconstruct recurrent laryngeal nerve